Alan B. Lancz & Associates’s Celanese CE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$478K Sell
7,275
-1,600
-18% -$83.5K 0.46% 60
2025
Q4
$375K Hold
8,875
0.33% 76
2025
Q3
$373K Hold
8,875
0.34% 79
2025
Q2
$491K Hold
8,875
0.49% 49
2025
Q1
$504K Sell
8,875
-1,200
-12% -$74.9K 0.54% 49
2024
Q4
$697K Sell
10,075
-1,150
-10% -$111K 0.71% 33
2024
Q3
$1.53M Hold
11,225
1.4% 15
2024
Q2
$1.51M Buy
+11,225
New +$1.72M 1.5% 15
2023
Q4
$1.81M Hold
11,625
1.9% 9
2023
Q3
$1.46M Hold
11,625
1.66% 13
2023
Q2
$1.35M Hold
11,625
1.44% 16
2023
Q1
$1.27M Hold
11,625
1.31% 16
2022
Q4
$1.41M Sell
11,625
-50
-0.4% -$4.96K 1.42% 13
2022
Q3
$1.05M Hold
11,675
1.25% 16
2022
Q2
$1.37M Sell
11,675
-675
-5% -$96.9K 1.36% 13
2022
Q1
$1.76M Hold
12,350
1.56% 11
2021
Q4
$2.08M Buy
+12,350
New +$2.01M 1.81% 10

Other funds holding CE

Alan B. Lancz & Associates's CE Position: Q1 2026 in Review

Alan B. Lancz & Associates reduced its Celanese (CE) stake by 18% in Q1 2026, selling an estimated $83.5K and leaving 7,275 shares worth $478K. The position accounts for 0.46% of the portfolio, ranked #60.

Alan B. Lancz & Associates first reported a position in CE in Q4 2021 and has held it in 17 quarters since. The position peaked at $2.08M in Q4 2021. 471 funds tracked by Wall St. Rank hold CE as of Q1 2026.

  • Alan B. Lancz & Associates held 7,275 shares of Celanese worth $478K as of Q1 2026.
  • Alan B. Lancz & Associates sold 1,600 Celanese shares in Q1 2026, an estimated $83.5K.
  • Celanese made up 0.46% of Alan B. Lancz & Associates's portfolio in Q1 2026, its #60 holding.
  • Alan B. Lancz & Associates first reported a position in Celanese in Q4 2021 and has held it in 17 quarters since.
  • Alan B. Lancz & Associates's Celanese position peaked at $2.08M in Q4 2021.
  • 471 funds tracked by Wall St. Rank held Celanese as of Q1 2026.

Based on Alan B. Lancz & Associates's 13F filing for Q1 2026, filed 5 May 2026.